tiprankstipranks
Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
US Market

Trevi Therapeutics (TRVI) Financial Statements

290 Followers

Trevi Therapeutics Financial Overview

Trevi Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.338; its P/E ratio is -8.28; Trevi Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -10.91M$ -7.80M$ -7.71M$ -7.02M$ -7.40M
EBITDA$ -10.87M$ -7.76M-$ -7.38M$ -7.97M
Net Income Common Stockholders$ -10.90M$ -7.82M$ -7.70M$ -7.14M$ -6.40M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 72.82M$ 82.97M$ 88.87M$ 94.15M$ 111.26M
Total Assets$ 78.56M$ 89.40M$ 95.90M$ 100.98M$ 115.96M
Total Debt$ 1.27M$ 1.34M$ 1.41M$ 1.47M$ 9.02M
Net Debt$ -71.55M$ -81.63M$ -87.46M$ -92.68M$ -102.24M
Total Liabilities$ 6.22M$ 6.86M$ 6.29M$ 5.90M$ 14.47M
Stockholders Equity$ 72.33M$ 82.55M$ 89.61M$ 95.07M$ 101.73M
Cash Flow-
Free Cash Flow$ -10.47M$ -6.38M-$ -9.91M$ -8.25M
Operating Cash Flow$ -10.47M$ -6.36M$ -7.28M$ -9.88M$ -8.20M
Investing Cash Flow$ -8.09M$ 12.85M$ 17.98M$ 19.64M$ 8.96M
Financing Cash Flow$ -28.00K$ -54.00K$ 1.51M$ -7.66M$ -1.70M
Currency in USD

Trevi Therapeutics Earnings and Revenue History

Trevi Therapeutics Debt to Assets

Trevi Therapeutics Cash Flow

Trevi Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis